Alnylam, Isis introduce new Regulus CEO

12/3/2007 | Forbes

Kleanthis G. Xanthopoulos has been appointed president and chief executive of Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals and Isis Pharmaceuticals that focuses on microRNA technology. Xanthopoulos joins the company from Anadys Pharmaceuticals, where he was co-founder, former president and CEO.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR